Association between microbiome and plasma proteome profile in COPD

M. Yavari Ramsheh (Leicester, United Kingdom), T. Cao (Leicester, United Kingdom), O. Elneima (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), K. Haldar (Leicester, United Kingdom), M. Barer (Leicester, United Kingdom), L. Ng (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom)

Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Session: Intercellular communication in tissue remodelling of chronic lung diseases
Session type: E-poster session
Number: 2702
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Yavari Ramsheh (Leicester, United Kingdom), T. Cao (Leicester, United Kingdom), O. Elneima (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), K. Haldar (Leicester, United Kingdom), M. Barer (Leicester, United Kingdom), L. Ng (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom). Association between microbiome and plasma proteome profile in COPD. 2702

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Association of the salivary microbiome with asthma exacerbations
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism
Source: Eur Respir J, 58 (1) 2003434; 10.1183/13993003.03434-2020
Year: 2021



Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


A comparative proteomic profiling of the human erythrocyte membrane in COPD patients
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009


Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019



Association between bacterial load and inflammatory gene expression in COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018


Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017



Association between triclosan exposure levels and gut microbiota in asthmatic mice.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017

Association of serum pneumoproteins with clinical course of COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014

Clinical phenotypes of exacerbation are associated with differences in microbial composition and diversity in COPD
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Oral microbiome and associations with chemical exposure, asthma and lung function
Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics
Year: 2017



Lung microbiome dynamics in COPD exacerbations
Source: Eur Respir J 2016; 47: 1082-1092
Year: 2016



Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes
Source: ERJ Open Res, 7 (3) 00915-2020; 10.1183/23120541.00915-2020
Year: 2021



A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006